glp 1 agonist drugs oral Market Overview: GLP-1 Agonists and the Obesity Market | Blog Danuglipron: An Oral GLP-1R Agonist
Description
Back Defining Moments Canada 'Early patients young lives saved'
However, concerns have been expressed regarding their safety profile
10.1016/j.apsb.2024.03.011 31 HernndezC.BogdanovP.CorralizaL.Garca-RamrezM.Sol-AdellC.ArranzJ
Hope DCD, Hinds CE, Lopes T, Vincent ML, Shrewsbury JV, Yu ATC, et al
Generally, the increase in heart rate with GLP-1 receptor agonists is small but clinically relevant as heart rate is a marker of cardiovascular disease [97]
Understanding the trajectory helps frame current purchasing decisions in proper context
